CGTBiologicFundamenta Therapeutics, Ltd.Phase 1
Chimeric Antigen Receptor T-cells (Chimeric Antigen Receptor T-cells)
Leukemia, Acute Lymphocytic (ALL); Leukemia, Acute Myelogenous (AML) · Platinum-Resistant Ovarian Carcinoma
#Platinum-ResistantOvarianCarcino#CGT#Phase1#인기#세포유전치료+5
효능 ORR 67%임상시험 63상태 ACTIVE